AI for diagnosing basal cell carcinoma
Part of Cancer clinical trials.
This study uses artificial intelligence to help diagnose basal cell carcinoma, a common type of skin cancer, from digital images of tissue samples. It may improve accuracy and speed of diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have tissue samples (slides) that are confirmed as basal cell carcinoma.
- The slides must be well-stained and well-preserved, allowing clear viewing under a microscope.
- The slides must be in good condition, without damage or fading, so they can be digitized.
- The original diagnosis of basal cell carcinoma must be certain, not uncertain or inconclusive.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an artificial intelligence program can correctly identify seborrheic keratosis from skin biopsy slides. If successful, it could help doctors diagnose this common skin condition faster and more accurately.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
This trial uses an advanced AI-assisted imaging device to see the edges of a common skin cancer called basal cell carcinoma before surgery. It may help doctors remove the cancer more precisely, possibly reducing the need for repeat procedures.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This trial tests how well artificial intelligence (AI) helps pathologists make diagnoses from digital tissue images. It may lead to faster and more accurate results for patients like you.
Hear when a new Basal Cell Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.